Linda Chang1, Vanessa Douet2, Cinnamon Bloss2, Kristin Lee2, Alexandra Pritchett2, Terry L Jernigan2, Natacha Akshoomoff2, Sarah S Murray2, Jean Frazier2, David N Kennedy2, David G Amaral2, Jeffrey Gruen2, Walter E Kaufmann2, B J Casey2, Elizabeth Sowell2, Thomas Ernst2. 1. From the Department of Medicine (L.C., V.D., K.L., A.P., T.E.), John A. Burns School of Medicine, University of Hawaii and The Queen's Medical Center, Honolulu; Department of Psychiatry, School of Medicine (C.B.), Departments of Psychiatry and Cognitive Science (T.L.J., N.A.), and Department of Pathology (S.S.M.), University of California San Diego, La Jolla; Department of Psychiatry (J.F., D.N.K.), University of Massachusetts Medical School, Boston; Department of Psychiatry and Behavioral Sciences (D.G.A.), University of California, Davis; Departments of Pediatrics and Investigative Medicine (J.G.), Yale Child Health Research Center, Yale University School of Medicine, New Haven, CT; Boston Children's Hospital (W.E.K.), Harvard Medical School, Boston, MA; Sackler Institute for Developmental Psychobiology (B.J.C.), Weil Cornell Medical College, New York, NY; Department of Pediatrics (E.S.), University of Southern California, Los Angeles; and Children's Hospital (E.S.), Los Angeles, CA. lchang@hawaii.edu. 2. From the Department of Medicine (L.C., V.D., K.L., A.P., T.E.), John A. Burns School of Medicine, University of Hawaii and The Queen's Medical Center, Honolulu; Department of Psychiatry, School of Medicine (C.B.), Departments of Psychiatry and Cognitive Science (T.L.J., N.A.), and Department of Pathology (S.S.M.), University of California San Diego, La Jolla; Department of Psychiatry (J.F., D.N.K.), University of Massachusetts Medical School, Boston; Department of Psychiatry and Behavioral Sciences (D.G.A.), University of California, Davis; Departments of Pediatrics and Investigative Medicine (J.G.), Yale Child Health Research Center, Yale University School of Medicine, New Haven, CT; Boston Children's Hospital (W.E.K.), Harvard Medical School, Boston, MA; Sackler Institute for Developmental Psychobiology (B.J.C.), Weil Cornell Medical College, New York, NY; Department of Pediatrics (E.S.), University of Southern California, Los Angeles; and Children's Hospital (E.S.), Los Angeles, CA.
Abstract
OBJECTIVE: The aims of the current study were to determine whether children with the 6 different APOE ε genotypes show differences in gray matter maturation, particularly for those with ε4 and ε2 alleles, which are associated with poorer outcomes in many neurologic disorders. METHODS: A total of 1,187 healthy children (aged 3-20 years, 52.1% boys, 47.9% girls) with acceptable data from the cross-sectional Pediatric Imaging Neurocognition and Genetics Study were evaluated for the effects of 6 APOE ε genotypes on macroscopic and microscopic cortical and subcortical gray matter structures (measured with 3-tesla MRI and FreeSurfer for automated morphometry) and on cognition (NIH Toolbox). RESULTS: Among APOE ε4 carriers, age-related changes in brain structures and cognition varied depending on genotype, with the smallest hippocampi in ε2ε4 children, the lowest hippocampal fractional anisotropy in younger ε4ε4 children, the largest medial orbitofrontal cortical areas in ε3ε4 children, and age-dependent thinning of the entorhinal cortex in ε4ε4 children. Younger ε4ε4 children had the lowest scores on executive function and working memory, while younger ε2ε4 children performed worse on attention tasks. Larger parietal gyri in the younger ε2ε4 children, and thinner temporal and cingulate isthmus cortices or smaller hippocampi in the younger ε4ε4 children, predicted poorer performance on attention or working memory. CONCLUSIONS: Our findings validated and extended prior smaller studies that showed altered brain development in APOE ε4-carrier children. The ε4ε4 and ε2ε4 genotypes may negatively influence brain development and brain aging at the extremes of age. Studying APOE ε polymorphisms in young children may provide the earliest indicators for individuals who might benefit from early interventions or preventive measures for future brain injuries and dementia.
OBJECTIVE: The aims of the current study were to determine whether children with the 6 different APOE ε genotypes show differences in gray matter maturation, particularly for those with ε4 and ε2 alleles, which are associated with poorer outcomes in many neurologic disorders. METHODS: A total of 1,187 healthy children (aged 3-20 years, 52.1% boys, 47.9% girls) with acceptable data from the cross-sectional Pediatric Imaging Neurocognition and Genetics Study were evaluated for the effects of 6 APOE ε genotypes on macroscopic and microscopic cortical and subcortical gray matter structures (measured with 3-tesla MRI and FreeSurfer for automated morphometry) and on cognition (NIH Toolbox). RESULTS: Among APOE ε4 carriers, age-related changes in brain structures and cognition varied depending on genotype, with the smallest hippocampi in ε2ε4 children, the lowest hippocampal fractional anisotropy in younger ε4ε4 children, the largest medial orbitofrontal cortical areas in ε3ε4 children, and age-dependent thinning of the entorhinal cortex in ε4ε4 children. Younger ε4ε4 children had the lowest scores on executive function and working memory, while younger ε2ε4 children performed worse on attention tasks. Larger parietal gyri in the younger ε2ε4 children, and thinner temporal and cingulate isthmus cortices or smaller hippocampi in the younger ε4ε4 children, predicted poorer performance on attention or working memory. CONCLUSIONS: Our findings validated and extended prior smaller studies that showed altered brain development in APOE ε4-carrier children. The ε4ε4 and ε2ε4 genotypes may negatively influence brain development and brain aging at the extremes of age. Studying APOE ε polymorphisms in young children may provide the earliest indicators for individuals who might benefit from early interventions or preventive measures for future brain injuries and dementia.
Authors: Qian Jun Yap; Irvin Teh; Paolo Fusar-Poli; Min Yi Sum; Carissa Kuswanto; Kang Sim Journal: J Neural Transm (Vienna) Date: 2013-01-18 Impact factor: 3.575
Authors: K Kantarci; V Lowe; S A Przybelski; S D Weigand; M L Senjem; R J Ivnik; G M Preboske; R Roberts; Y E Geda; B F Boeve; D S Knopman; R C Petersen; C R Jack Journal: Neurology Date: 2011-12-21 Impact factor: 9.910
Authors: D M Alexander; L M Williams; J M Gatt; C Dobson-Stone; S A Kuan; E G Todd; P R Schofield; N J Cooper; E Gordon Journal: Biol Psychol Date: 2007-03-16 Impact factor: 3.251
Authors: Yawu Liu; Teemu Paajanen; Eric Westman; Lars-Olof Wahlund; Andrew Simmons; Catherine Tunnard; Tomasz Sobow; Petroula Proitsi; John Powell; Patrizia Mecocci; Magda Tsolaki; Bruno Vellas; Sebastian Muehlboeck; Alan Evans; Christian Spenger; Simon Lovestone; Hilkka Soininen Journal: J Alzheimers Dis Date: 2010 Impact factor: 4.472
Authors: Sandra Weintraub; Sureyya S Dikmen; Robert K Heaton; David S Tulsky; Philip D Zelazo; Patricia J Bauer; Noelle E Carlozzi; Jerry Slotkin; David Blitz; Kathleen Wallner-Allen; Nathan A Fox; Jennifer L Beaumont; Dan Mungas; Cindy J Nowinski; Jennifer Richler; Joanne A Deocampo; Jacob E Anderson; Jennifer J Manly; Beth Borosh; Richard Havlik; Kevin Conway; Emmeline Edwards; Lisa Freund; Jonathan W King; Claudia Moy; Ellen Witt; Richard C Gershon Journal: Neurology Date: 2013-03-12 Impact factor: 9.910
Authors: Elizabeth R Sowell; Paul M Thompson; Suzanne E Welcome; Amy L Henkenius; Arthur W Toga; Bradley S Peterson Journal: Lancet Date: 2003-11-22 Impact factor: 79.321
Authors: L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn Journal: JAMA Date: 1997 Oct 22-29 Impact factor: 56.272
Authors: Amy E Taylor; Philip A I Guthrie; George Davey Smith; Jean Golding; Naveed Sattar; Aroon D Hingorani; John E Deanfield; Ian N M Day Journal: Biol Psychiatry Date: 2011-01-07 Impact factor: 13.382
Authors: Chandra A Reynolds; Andrew Smolen; Robin P Corley; Elizabeth Munoz; Naomi P Friedman; Soo Hyun Rhee; Michael C Stallings; John C DeFries; Sally J Wadsworth Journal: Neurobiol Aging Date: 2019-04-18 Impact factor: 4.673
Authors: Zachary A Miller; Lynne Rosenberg; Miguel A Santos-Santos; Melanie Stephens; Isabel E Allen; H Isabel Hubbard; Averill Cantwell; Maria Luisa Mandelli; Lea T Grinberg; William W Seeley; Bruce L Miller; Gil D Rabinovici; Maria Luisa Gorno-Tempini Journal: JAMA Neurol Date: 2018-06-01 Impact factor: 18.302